Literature DB >> 8597756

HTLV-I screening in Britain. Antenatal screening is important.

J N Weber, G P Taylor.   

Abstract

Entities:  

Mesh:

Year:  1996        PMID: 8597756      PMCID: PMC2350513          DOI: 10.1136/bmj.312.7032.706b

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I.

Authors:  E L Murphy; B Hanchard; J P Figueroa; W N Gibbs; W S Lofters; M Campbell; J J Goedert; W A Blattner
Journal:  Int J Cancer       Date:  1989-02-15       Impact factor: 7.396

2.  Infection with human T cell leukaemia/lymphoma virus type I in patients attending an antenatal clinic in London.

Authors:  J H Tosswill; A E Ades; C Peckham; P P Mortimer; J N Weber
Journal:  BMJ       Date:  1990-07-14

3.  HTLV-I screening in Britain.

Authors:  A Pagliuca; R Pawson; G J Mufti
Journal:  BMJ       Date:  1995-11-18

4.  Use of dried blood spots for the detection and confirmation of HTLV-I specific antibodies for epidemiological purposes.

Authors:  S P Parker; M B Taylor; A E Ades; W D Cubitt; C Peckham
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

5.  A sero-epidemiological study on mother-to-child transmission of HTLV-I in southern Kyushu, Japan.

Authors:  T Oki; M Yoshinaga; H Otsuka; K Miyata; S Sonoda; Y Nagata
Journal:  Asia Oceania J Obstet Gynaecol       Date:  1992-12
  5 in total
  2 in total

1.  Human T cell leukaemia/lymphoma virus infection in pregnant women in the United Kingdom: population study.

Authors:  A E Ades; S Parker; J Walker; M Edginton; G P Taylor; J N Weber
Journal:  BMJ       Date:  2000-06-03

2.  Hepatitis E virus infection is highly prevalent among pregnant women in Accra, Ghana.

Authors:  Andrew A Adjei; Yao Tettey; John T Aviyase; Clement Adu-Gyamfi; Samuel Obed; Julius A A Mingle; Patrick F Ayeh-Kumi; Theophilus K Adiku
Journal:  Virol J       Date:  2009-07-20       Impact factor: 4.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.